Europe Contract Development and Manufacturing Organization (CDMO) Market - Size, Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

Europe Contract Development and Manufacturing Organization (CDMO) Market Overview

Contract development and manufacturing organizations play a pivotal role in the pharmaceutical and biotechnology ecosystem by supporting companies at all stages of drug discovery, development, and manufacturing. The market is expanding steadily due to increasing outsourcing trends, complex biologics pipelines, and demand for flexible manufacturing solutions. The market was valued at USD 70.86 Billion in 2025. The growth is further supported by rising Manufacturing investments, strategic partnerships, and technological advancements, improving scalability, compliance, and production efficiency.

Europe Contract Development and Manufacturing Organization (CDMO) Market Growth Drivers

Cost-Efficient Biologics Capacity Expansion to Accelerate the Market Landscape

The expansion of cost-efficient biologics manufacturing capacity across Europe is a key driver supporting the contract development and manufacturing organization (CDMO) market. In August 2025, Rezon Bio announced its launch as a European biologics CDMO with mirrored, regulator-audited facilities in Poland, offering end-to-end services from cell line development to GMP manufacturing and commercialization. The company integrates single-use technologies and AI-enabled process optimization to shorten development timelines and reduce costs for clients. Such investments strengthen regional outsourcing capabilities, enhance competitiveness, and support the sustained expansion of the market.

Europe Contract Development and Manufacturing Organization (CDMO) Market Trends

Some of the notable trends in the market include strategic facility acquisitions, capacity expansion, and the increasing expansion of integrated CDMO service models.

Strategic Facility Acquisitions and Capacity Expansion to Boost the Market Value

The strategic acquisitions of advanced manufacturing facilities are emerging as a key trend, strengthening service capabilities and geographic reach in the market. Companies are increasingly investing in integrated drug product and device assembly solutions to meet growing demand for biologics and injectable therapies. For instance, in October 2025, Terumo Corporation enhanced its European footprint by acquiring a pharmaceutical production facility from WuXi Biologics in Leverkusen, strengthening fill-finish and device assembly capabilities. Such strategic expansions are expected to accelerate innovation and drive sustained market growth across Europe.

Growing Expansion of Integrated Service Models is Likely to Enhance the Contract Development and Manufacturing Organization (CDMO) Market Demand

The market is witnessing a growing trend toward the formalization of integrated CMO/CDMO service models, enabling pharmaceutical companies to optimize existing infrastructure and diversify revenue streams through outsourcing partnerships. For instance, in June 2024, Towa International announced the launch of an official CMO/CDMO business line at its Barcelona facility to support external drug development and manufacturing needs. Such strategic initiatives reflect increasing collaboration across the pharmaceutical value chain, strengthening service capacity and innovation capabilities, and are expected to drive sustained market growth across the region.

Europe Contract Development and Manufacturing Organization (CDMO) Market Segmentation

Europe Contract Development and Manufacturing Organization (CDMO) Market Share

Oncological Diseases Segment is Poised to Dominate the Market Segmentation by Therapeutic Area

The market is segmented by therapeutic area into oncology, cardiovascular, infectious, and other therapeutic areas. Among these, oncological diseases are expected to lead, driven by increasing cancer prevalence and the growing need for specialized biologics development and manufacturing capabilities. According to the Organisation for Economic Co-operation and Development (OECD), cancer remains a major public health challenge in the United Kingdom, with 1 in 4 premature deaths projected to be cancer-related between 2023 and 2050. This escalating disease burden is reinforcing demand for advanced outsourcing services, supporting sustained segment expansion.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Europe Contract Development and Manufacturing Organization (CDMO) Market Analysis by Region

The regions included in the report are Germany, the United Kingdom, France, Italy, and others. Among these, Germany leads the market, supported by its robust pharmaceutical manufacturing ecosystem, skilled workforce, and strong investment pipeline. In May 2025, Famar, backed by MidEuropa, announced the acquisition of a sterile manufacturing facility in Homburg from MiP Pharma to expand aseptic and lyophilized fill-finish capabilities. This transaction strengthens Germany’s position by addressing capacity gaps in high-quality sterile infrastructure and enhancing regional CDMO competitiveness.

Leading Players in the Europe Contract Development and Manufacturing Organization (CDMO) Market

Other key players in the market are Patheon Pharma Services (Thermo Fisher Scientific Inc.), Famar SA, Lonza Group, LTS Lohmann Therapie-Systeme AG, Aenova Holding GmBH, Fareva SA, FUJIFILM Diosynth Biotechnologies, eXmoor Pharma, B. Braun SE, and Sanofi.

Key Questions Answered in the Europe Contract Development and Manufacturing Organization (CDMO) Market

• What was the Europe contract development and manufacturing organization (CDMO) market value in 2025?
• What is the Europe contract development and manufacturing organization (CDMO) market forecast outlook for 2026-2035?
• What major factors aid the demand for the Europe contract development and manufacturing organization (CDMO) market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major Europe contract development and manufacturing organization (CDMO) market trends?
• Which service type is expected to dominate the market segment?
• Which therapeutic area is projected to lead the market segment?
• Which end user is anticipated to drive the market segment?
• Who are the key players in the Europe contract development and manufacturing organization (CDMO) market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?